Table 1 Participant characteristics (N = 81). N(%) or median [IQR]
Variable | N (%) or Median (IQR) |
|---|---|
Age (years) | 12.02 [10.72, 14.37] |
Sex: Female | 29 (35.8) |
Race / Ethnicity: Hispanic | 46 (56.8) |
Non-Hispanic Black | 11 (13.6) |
Non-Hispanic Other | 12 (14.8) |
Non-Hispanic White | 12 (14.8) |
CDC BMI Percentile | 79.90 [54.20, 93.50] |
Household Income | $45,000 [$15,000 - $19,999, $55,000 - $59,999] |
Parental Education Level: Grades 1–11 | 10 (12.3) |
GED or 12th grade | 26 (32.1) |
> 12th grade | 45 (55.6) |
Medication Use: Albuterol as needed | 17 (21.0) |
Low dose ICS1 or LTRA2 | 23 (28.4) |
Low dose ICS + LABA3 or medium dose ICS | 10 (12.3) |
Medium dose ICS + LABA | 15 (18.5) |
High dose ICS or high dose ICS + LABA | 16 (19.8) |
Baseline Asthma Control: Well controlled (cACT or ACT ≥ 20) | 57 (72.2) |
Not well controlled (cACT or ACT < 20) | 22 (27.8) |
FEV1% Predicted Pre Bronchodilator (subject median) | 94.37 [85.79, 108.01] |
FVC % Predicted Pre Bronchodilator (subject median) | 106.58 [95.57, 118.54] |
FEV1/FVC % Predicted Pre Bronchodilator (subject median) | 90.02 [85.14, 95.18] |
FEV1% Change Post Bronchodilator (subject median) | 8.23 [5.14, 12.70] |
FVC % Change Post Bronchodilator (subject median) | 1.25 [-0.21, 3.57] |
FEV1/FVC % Change Post Bronchodilator (subject median) | 7.37 [3.45, 10.44] |
Number of Visits: 1 | 26 (32.1) |
2 | 8 ( 9.9) |
3 | 15 (18.5) |
4 | 28 (34.6) |
5 | 4 ( 4.9) |